Deva Holding AS - Cerkezkoy Subesi recalls Temozolomide Capsules, 180 mg, packaged in a) 5-count bottle (NDC 67877-541-07), b) 14-count bottle (NDC 67877-541-14),
Deva Holding recalls Temozolomide 180mg capsules due to possible cross contamination with beta-lactam products during manufacturing. Affected lots expire through 2021.
Lower-risk recall
CGMP Deviations: product was manufactured that did not prevent possible cross contamination with beta lactam products.
Contact the company & request your remedy
What happened, in plain English
Deva Holding is recalling Temozolomide 180mg capsules that may have been contaminated with beta-lactam products during manufacturing. This could lead to unintended medication interactions for patients using these cancer treatments. Read more at govinfonow.com/recall/38273-deva-holding-temozolomide-capsules-recall-cross-contamination-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/38273-deva-holding-temozolomide-capsules-recall-cross-contamination-risk · Updated October 5, 2026 · FDA enforcement record: FDA #D-1512-2019
Cite this page
“Deva Holding Temozolomide Capsules Recall: Cross Contamination Risk.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/38273-deva-holding-temozolomide-capsules-recall-cross-contamination-risk. Based on FDA recall #D-1512-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1512-2019%22&limit=1).
Why it’s dangerous
The manufacturing process had cross contamination with beta-lactam products, which could cause unintended medication interactions. Beta-lactam antibiotics like penicillin may interact with Temozolomide, potentially reducing effectiveness or causing adverse reactions.
Who’s affected
Patients prescribed Temozolomide for cancer treatment who received these specific lots. Those with compromised immune systems or using other antibiotics may be at higher risk.
How to tell if you have this one
Check for 5-count or 14-count bottles labeled Temozolomide 180mg with NDC codes 67877-541-07 or 67877-541-14. The product was manufactured by Deva Holding in Turkey and distributed by Ascend Laboratories in New Jersey.
- Brand
Deva Holding- Category
Drug
All 6 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class II- Status
Terminated- Distribution
Nationwide in the USA.- NDC
67877-537-07, 67877-537-14, 67877-538-07, 67877-538-14, 67877-539-07, 67877-539-14, 67877-540-07, 67877-540-14, 67877-541-07, 67877-541-14, 67877-542-07
| Recall number | Product, codes & lots | Quantity |
|---|---|---|
| D-1508-2019 | Temozolomide Capsules, 5 mg, packaged in a) 5-count bottle (NDC 67877-537-07), b) 14-count bottle (NDC 67877-537-14), Rx only, Manufactured by: Deva Holding A.S., 1 Merkez Mahallesi, Istanbul, Turkey 34303, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054.; Lot #: a) A062238, A062118, A062115, A062112, A062100, Exp 08/31/2019; A068946, Exp 04/30/2020; A071733, Exp 09/30/2020; b) A062194, A062181, A62275, A062218, Exp 08/31/2019; A069154, Exp 04/30/2020; A071734, A071783, A071735, Exp 09/30/2020 | a) 5736 bottles; b) 8460 bottles |
| D-1509-2019 | Temozolomide Capsules, 20 mg, packaged in a) 5-count bottle (NDC 67877-538-07), b) 14-count bottle (NDC 67877-538-14), Rx only, Manufactured by: Deva Holding A.S., 1 Merkez Mahallesi, Istanbul, Turkey 34303, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054.; Lot #: a) A061688, A061687, A061685, Exp 07/31/2019; A068994, Exp 04/30/2020; A071853, Exp 09/30/20; b) A061794, A061833, A061822, Exp 07/31/2019; A069115, Exp 04/30/2020; A071855, A071854, Exp 09/30/2020 | a) 11376 bottles; b) 13620 bottles |
| D-1510-2019 | Temozolomide Capsules, 100 mg, packaged in a) 5-count bottle (NDC 67877-539-07), b) 14-count bottle (NDC 67877-539-14), Rx only, Manufactured by: Deva Holding A.S., 1 Merkez Mahallesi, Istanbul, Turkey 34303, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054.; Lot #: a) A061783, A061782, A061781, Exp 07/31/2019; A069128, Exp 05/31/2020; A071923, Exp 09/30/20; b) A061874, A061861, A061896, Exp 07/31/2019; A069326, Exp 05/31/2020; A071924, A071977, A071925, Exp 09/30/2020 | a) 13752 bottles; b) 15696 bottles |
| D-1511-2019 | Temozolomide Capsules, 140 mg, packaged in a) 5-count bottle (NDC 67877-540-07), b) 14-count bottle (NDC 67877-540-14), Rx only, Manufactured by: Deva Holding A.S., 1 Merkez Mahallesi, Istanbul, Turkey 34303, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054.; Lot #: a) A063581, A063462, A063460, Exp 09/30/2019; A063582, Exp 10/31/2019; A069129, Exp 05/31/2020; A071801, Exp 09/30/2020; b) A063639, A063624, A063609, Exp 09/30/2019; A063657, Exp 10/31/2019; A069366, Exp 05/31/2020; A071817, A071819, A071818, Exp 09/30/2020 | a) 7380 bottles; b) 10332 bottles |
| D-1512-2019 | Temozolomide Capsules, 180 mg, packaged in a) 5-count bottle (NDC 67877-541-07), b) 14-count bottle (NDC 67877-541-14), Rx only, Manufactured by: Deva Holding A.S., 1 Merkez Mahallesi, Istanbul, Turkey 34303, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054.; Lot #: a) A061858, A061857, A061856, A061860, A061859, Exp 07/31/2019; A069401, A069402, Exp 05/31/2020; A071978, Exp 09/30/2020; A076736, A076735, Exp 04/30/2021; b) A062031. A062015, A062014, A062050, A062038, Exp 07/31/2019; A069521, A069470, Exp 05/31/2020; A071979, A072014, A072013, Exp 09/30/2020; A076739, A076738, A076737, Exp 04/30/2021 | a) 5052 bottles; b) 3816 bottles |
| D-1513-2019 | Temozolomide Capsules, 250 mg, 5-count bottle, Rx only, Manufactured by: Deva Holding A.S., 1 Merkez Mahallesi, Istanbul, Turkey 34303, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-542-07.; Lot #: A062228, A062227, A062226, A062295, A062294, Exp 08/31/2019; A069325, A069323, Exp 05/31/2020; A072015, Exp 10/31/2020; A076611, A076609, A076608, A076607, Exp 04/30/2021 | 11472 bottles |
What to do — step by step
Check Product Details
Look for the NDC codes 67877-541-07 or 67877-541-14 on the bottle label to confirm if your product is affected.
Questions people ask
Is this product safe to use?
The recall is due to possible cross contamination with beta-lactam products during manufacturing, which could cause unintended medication interactions. Patients should contact their healthcare provider for guidance.
How do I know if my product is affected?
Check for the NDC codes 67877-541-07 (5-count bottle) or 67877-541-14 (14-count bottle) on the product label.
What should I do if I have this product?
The recall does not specify a remedy, so patients should consult their healthcare provider about whether to continue using the product.
Contact Deva Holding
We’ve drafted a message you can send Deva Holding to request your refund or repair — edit it as you like.
Subject: Recall D-1512-2019 — Deva Holding Deva Holding Hello, I own a Deva Holding that is covered by recall D-1512-2019 from Deva Holding. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1512-2019 (July 16, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1512-2019 to see it in context.
- Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.